Skip to main content
Log in

The moral philosophical foundation of pharmaceutical medicine: basic ethical commodities and principles

  • Point of View
  • Published:
International Journal of Pharmaceutical Medicine Aims and scope Submit manuscript

Summary

  1. 1.

    In pharmaceutical medicine, benefit and risk are fundamental, intangible ethical commodities determined normatively in recourse to empirically proven preparation characteristics. As normative value judgements, benefit and risk cannot be offset against each other. For this reason it is proposed to replace the term ‘benefit/risk-balance’ by the term ‘benefit/risk-relationship’. The logical gap left by the comparison of benefit and risk is closed by another normative determination: their relationship is judged to be favourable, unfavourable, or unacceptable.

  2. 2.

    For the management of uncertainty, ethical principles are important decision-/action-guiding tools. As a general ethical model for pharmaceutical medicine, a three-tiered construction is proposed

The justification tier forms the basis of the construction and contains the culture-defining principle of human dignity that should be viewed as an absolute, unrestrictable, transcendental and universal principle. Within the framework of ethical deliberation, the principle of human dignity systematically holds open the door to recourse and may be seen as a pragmatic substitute for metaphysics.

The justification tier holds up the general action tier, which involves the implementation of actions once they have been decided upon. This second tier is characterized by the cardinal principle of responsibility — which is absolute and unrestrictable. As a primarily amoral principle, responsibility is initially ethically neutral, requiring a specific context to acquire its function as a moral philosophical ‘stabilizer’ for the consistent implementation and defence of decisions reached.

The construction’s roof is the special action tier, at which morally relevant decisions to act are reached de facto. Ethical reflection draws here on the action-guiding principles of respect for beneficence, for non-maleficence, for autonomy and for justice. These traditional principles have a relative status; they are always valid prima facie and remain so provided that, in a specific situation, they are not forced to retire behind another, overriding principle or do not become restricted in an individual case. It is proposed to apply these principles only in the context of responsibility of the decision-maker, and this in turn should have its foundation in the principle of human dignity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table 1
Figure 1

Similar content being viewed by others

References

  1. Wagner W. Human dignity: plea for a forgotten principle in medical ethics. Brussels: Lecture at the European Parliament; 29 September 1997.

    Google Scholar 

  2. Wagner W. The management of uncertainty: risks of risk/benefit analysis in pharmaceutical research. In Bayertz K, Stolte H, Zimmermann U eds. Ethical dimensions of technology transfer in biomedicine. Frankfurt am Main: Peter Lang, 1993.

    Google Scholar 

  3. Wagner W, Herrmann WM. Ethische Grundlagen und Probleme der Klinischen Pharmakologie. In Kuemmerle HP, Hitzenberger G, Spitzy KH eds. Klinische Pharmakologie, 4th edn. Landsberg: Ecomed; 1998.

    Google Scholar 

  4. Bayertz K. Die Idee der Verantwortung: Zur erstaunlichen Karriere einer ethischen Kategorie. In Wagner W ed. Arzneimittel und Verantwortung. Grundlagen und Methoden der Pharmaethik. Berlin: Springer, 1993.

    Google Scholar 

  5. Beauchamp TL, Childress JF. Principles of biomedical ethics, 3rd edn. New York: Oxford University Press,1989.

    Google Scholar 

  6. Ritter J, Gründer K eds. Historisches Wörterbuch der Philosophie. Band 5. Darmstadt: Wissenschaftliche Buchgesellschaft, 1980.

    Google Scholar 

  7. Kant I. Grundlegung zur Metaphysik der Sitten. Band 4. Akademie-Ausgabe der Preußischen Sammlung der Wissenschaften. Berlin 1902 ff. Nachdruck: Berlin 1968. Berlin: De Gruyter; 1978.

    Google Scholar 

  8. Jonas H. Das Prinzip Verantwortung. Versuch einer Ethik für die technologische Zivilisation. Frankfurt am Main: Insel, 1979.

    Google Scholar 

  9. Wagner W. Verantwortung als Kardinalprinzip der Pharmaethik. In Wagner W ed. Arzneimittel und Verantwortung. Grundlagen und Methoden der Pharmaethik. Berlin: Springer, 1993.

    Chapter  Google Scholar 

  10. Hole G. Schuld und Schuldgefühle. In Pöldinger W, Wagner W eds. Aggression, Autoaggression, Familie und Gesellschaft. Berlin: Springer, 1989.

    Google Scholar 

  11. Spicer CM. Theories and methods in bioethics: principlism and its critics. Kennedy Institute of Ethics Journal 1995; 5(3): VII–IX.

    Article  Google Scholar 

  12. Veatch RM. Resolving conflicts among principles: ranking, balancing, and specifying. Kennedy Institute of Ethics Journal 1995; 5(3): 199–218.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge the support provided by Sarah Kirkby (Bad Oeynhausen) and Sabine Kober (Hanover) in preparing this publication.

Competing interests

None

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner, W., Herrmann, W.M. The moral philosophical foundation of pharmaceutical medicine: basic ethical commodities and principles. International Journal of Pharmaceutical Medicine 14, 129–136 (2000). https://doi.org/10.1097/00124363-200006000-00006

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1097/00124363-200006000-00006

Keywords

Navigation